The key problems in benign prostatic hyperplasia and lower urinary tract symptoms medical treatment
10.3760/cma.j.issn.1000-6702.2018.02.001
- VernacularTitle:再谈良性前列腺增生与下尿路症状药物治疗中的几个关键问题
- Author:
Jianye WANG
1
;
Ming LIU
Author Information
1. 100730,北京医院泌尿外科国家老年医学中心
- Keywords:
Benign prostatic hyperplasia;
5α reductase inhibitor;
Treatment
- From:
Chinese Journal of Urology
2018;39(2):81-84
- CountryChina
- Language:Chinese
-
Abstract:
The relationship between benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) in elderly men is very close.Although medical therapy plays an important role in the treatment of BPH/LUTS,there are still some unclear and urgent problems in the pharmaceutical treatment,including how to improve patients' symptoms and delay the clinical progression.There are a plenty of medicines for BPH/LUTS treatment,but how to make a reasonable choice,what is the evidence for the combination of those medicines and whether they may cause side effects? This review will focus on these key and controversial problems by literature review.
